Matches in Nanopublications for { ?s ?p "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 16 of
16
with 100 items per page.
- assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1168003.RAWNMvaq-_L9LzaLULrVsZb5U7R_jfU0uV1957VmQF3aA130_assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1168003.RAWNMvaq-_L9LzaLULrVsZb5U7R_jfU0uV1957VmQF3aA130_provenance.
- NP307809.RAtzXeGfp2hW8eF_b5pIsd0uUzJiyhou91XeGLFq9DT5s130_assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307809.RAtzXeGfp2hW8eF_b5pIsd0uUzJiyhou91XeGLFq9DT5s130_provenance.
- assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP965856.RArqD-mlKxDxlNBMbkibEHyxyo7-piUvUHARBlhufYfQU130_assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965856.RArqD-mlKxDxlNBMbkibEHyxyo7-piUvUHARBlhufYfQU130_provenance.
- NP307840.RA69GkJZOTuJJ_J4-sNQxbFQYpdlRgg_T2Zyqv-D_L8qo130_assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307840.RA69GkJZOTuJJ_J4-sNQxbFQYpdlRgg_T2Zyqv-D_L8qo130_provenance.
- NP307856.RAw0GRdRvfCE2J9huzK_Kg4FdjpqUzpqjblM6KY53sniM130_assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307856.RAw0GRdRvfCE2J9huzK_Kg4FdjpqUzpqjblM6KY53sniM130_provenance.
- NP307778.RAOFUfIPghWCbiGz4Q_rdr91zKsexbuh0Txf_99OVTOZ8130_assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307778.RAOFUfIPghWCbiGz4Q_rdr91zKsexbuh0Txf_99OVTOZ8130_provenance.
- NP965859.RAHkiVQeJrBF6CC8RMUkSW5SKnrhAx4QRm_tRkg-co5_4130_assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965859.RAHkiVQeJrBF6CC8RMUkSW5SKnrhAx4QRm_tRkg-co5_4130_provenance.
- NP1168010.RAGbZQaOCguOPnoaCGf2OSCsJlwIzxurTKbB3upw5VVLQ130_assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1168010.RAGbZQaOCguOPnoaCGf2OSCsJlwIzxurTKbB3upw5VVLQ130_provenance.
- NP1168012.RAL8VO2e1Q3km8KS9VSYGbJ4ICTDfgyLF9dXw9A1UBcYE130_assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1168012.RAL8VO2e1Q3km8KS9VSYGbJ4ICTDfgyLF9dXw9A1UBcYE130_provenance.
- NP1168006.RA4q6v303H3jy1q4gzCfcel2CbIuS7ZcAno56dUgUAEJ0130_assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1168006.RA4q6v303H3jy1q4gzCfcel2CbIuS7ZcAno56dUgUAEJ0130_provenance.
- NP965855.RAxiSwReT0DdBhRRtDAF_u1M2yMmKXe5pBQzztlIH_Vpk130_assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965855.RAxiSwReT0DdBhRRtDAF_u1M2yMmKXe5pBQzztlIH_Vpk130_provenance.
- NP965858.RA6kazb7kl1Tm0-oDggmUY-wmI6Uu0bKbifLzY3Ktax-k130_assertion description "[CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965858.RA6kazb7kl1Tm0-oDggmUY-wmI6Uu0bKbifLzY3Ktax-k130_provenance.